Chemoinformaics analysis of 2-(2,4-DIMETHOXYPHENYL)-7-METHOXYCHROMEN-4-ONE
| Molecular Weight | 312.321 | nRot | 4 |
| Heavy Atom Molecular Weight | 296.193 | nRig | 18 |
| Exact Molecular Weight | 312.1 | nRing | 3 |
| Solubility: LogS | -5.567 | nHRing | 1 |
| Solubility: LogP | 3.741 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 17 |
| nHA | 5 | APOL | 44.7387 |
| nHD | 0 | BPOL | 23.8633 |
| QED | 0.738 |
| Synth | 1.993 |
| Natural Product Likeliness | 0.386 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.998 |
| Pgp-sub | 0.003 |
| HIA | 0.006 |
| CACO-2 | -4.653 |
| MDCK | 0.0000516 |
| BBB | 0.119 |
| PPB | 0.836515 |
| VDSS | 0.82 |
| FU | 0.116245 |
| CYP1A2-inh | 0.941 |
| CYP1A2-sub | 0.967 |
| CYP2c19-inh | 0.82 |
| CYP2c19-sub | 0.601 |
| CYP2c9-inh | 0.74 |
| CYP2c9-sub | 0.938 |
| CYP2d6-inh | 0.5 |
| CYP2d6-sub | 0.958 |
| CYP3a4-inh | 0.88 |
| CYP3a4-sub | 0.555 |
| CL | 6.048 |
| T12 | 0.138 |
| hERG | 0.31 |
| Ames | 0.721 |
| ROA | 0.07 |
| SkinSen | 0.244 |
| Carcinogencity | 0.15 |
| EI | 0.786 |
| Respiratory | 0.393 |
| NR-Aromatase | 0.811 |
| Antiviral | Yes |
| Prediction | 0.859025 |